Hemostasis and Tissue Sealing Agents Market Report

Hemostasis and Tissue Sealing Agents Market Analysis Report, By Product (Topical Hemostats, Adhesives & Tissue Sealants), By Region, And Segment Forecasts, 2012 - 2022

  • Published Date: Mar, 2018
  • Base Year for Estimate: 2016
  • Report ID: 978-1-68038-597-7
  • Format: Electronic (PDF)
  • Historical Data: 2014-2016
  • Number of Pages: 85

Industry Insights

The global hemostasis and tissue sealing agents market size was valued at USD 3.8 billion in 2014. Hemostats and sealants are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. The industry is expected to witness lucrative growth over the next seven years owing to, an increase in demand supported by rising surgery volumes. Growth in geriatric population and increasing prevalence of chronic conditions are the impact rendering drivers of this industry. As per the CDC statistics, over 45% of the American population suffers from at least one chronic condition requiring critical care.

U.S hemostasis & tissue sealing agents market

Geriatric patients require critical care and are prone to injuries and wounds that take a lot of time to heal. With increasing demographic tilt towards an active lifestyle, the cases of routine injuries and wounds are on a rise, which is expected to affect growth over the forecast period. Chronic diseases ultimately lead to surgical procedures to be performed on the patient, which in turn boosts the market growth. Hernia fixation, diabetes, spinal injuries, ophthalmic injuries and replacements, urological disorders, and burns are a few chronic conditions requiring these products.

Hemostasis devices and sealants are used to prevent blood loss in various conditions. Their preference over other wound closure methods had led to its increasing use in multiple conditions, especially in endoscopic procedures. From mild injuries to burns and neurosurgical management, all are catered to by the hemostasis and tissue sealing agents market. Since 2006, post a study conducted and published by the National Centre for Biotechnology Information, hemostatic products have a wide range of applicability in the treatment of urology. Minimally invasive surgeries of urology are particularly making use of hemostatic solutions, thereby promoting its growth.

The highest demand for these products is witnessed in cardiovascular conditions followed by general surgeries. Higher application in cardiovascular disorders is attributed to better clinical results obtained by the use of sealants and hemostats as compared to other wound closure techniques.

Lack of reimbursements for these products may restrain the growth of the market to a certain extent. Increasing cost of surgical procedures and high price of surgical products is also expected to challenge the growth of this market to a certain extent.

Product Insights

Key product segments analyzed in this study include topical hemostats and tissue sealants. The topical hemostats are further classified into mechanical, active, and flow-able hemostats. Topical hemostats are generally used with conventional treatment to provide cost-efficiency, quick and easy absorbability of the hemostatic agent, minimal tissue reactivity and non-antigenicity.

Hemostasis involves the completion of coagulation, fibrinolysis, and platelet aggregation pathways by the activation of these factors. Hemostat consists of the hemostatic agents and their delivering system, which maybe a prefilled syringe or ready-to-use applicators.

Global hemostasis & tissue sealing agents market

Adhesive and sealants play a prominent role in controlling blood loss during surgeries. They function by binding with and sealing the damaged tissues. The binding leads to the development of a barrier over the injuries and surgical wound and helps promote coagulation.

The factors promoting their demand over sutures are faster procedure rate, minimal invasion, reduced post-surgical infections, and prevention of exudation of other body fluids. These are further sub-segmented on the basis of sealants used into synthetic, natural, and adhesion barrier products.

Regional Insights

North America held the largest share of the hemostasis and tissue sealing agent industry owing to growing prevalence of cardiovascular disorders, diabetes, and cancer within this region. Europe held the second largest market in 2014 and is expected to grow at a CAGR of around 8% over the forecast period. Launch of advanced and innovative hemostat products such as FLOSEAL, TISEEL and HEMOPATCH is expected to propel the demand for these products in the European market. Europe hemostasis and tissue sealing agents market is expected to be driven due to the rise in geriatric population base, which is expected to ultimately lead to higher number of surgeries.

The major factor responsible for the large share is aggressive marketing of such devices in this region. Other factors fostering growth are the regular launch of new products, increasing applications of such devices in surgeries and other medical applications along with increasing demand for sealing agents that minimize post-operative complications and increase the speed of healing. Adhesives and sealants account for a large share of the North American market.

Asia Pacific is expected to be a lucrative market over the forecast period due to increased medical tourism and surgical procedures. Liberal policies coupled with cost effective environment are the major drivers for the market growth over the forecast period. It is anticipated to gain over 25.0% of the share by 2022. India, China and Japan are the leading countries in the Asia Pacific with presence of relatively more developed healthcare infrastructure, advanced treatments, and large pool of patients. Market in Malaysia, Singapore and other Asian countries is expanding at a faster pace with booming medical tourism industry and improving healthcare services with government support.

Competitive Insights

Key players include CryoLife, C. R. Bard, B. Braun, and Advance Medical Solutions Group. Pfizer is expected to gain share on the pretext of its acquisition of King Pharmaceuticals, which has been a major contributor to the hemostasis and tissue sealing agents market. Strategic trends expected to be followed by the players include tie-ups with hospitals and care centers, R&D in the field of formulation development, incorporation of bacteriostatic properties, and aggressive marketing plans for natural adhesives, especially fibrin sealants.

These players are also involved in mergers and acquisitions aimed at ensuring sustainability and expanding regional presence, for instance, in January 2015; B. Braun signed an agreement with Cohera Medical Inc. for the distribution of TissuGlu in Germany, Portugal, and Spain. B. Braun is expected to promote the product through its various commercial channels in all the three regions of Europe. Companies such as Advanced Medical Solutions Group plc own direct sales force team in Germany, UK and Russia to market products effectively in Europe. Companies are now introducing cost effective hemostasis and tissue sealing agents to expand their customer base and this expected to contribute to the rising demand for these products in emerging countries.

Report Scope



Base year for estimation


Actual estimates/Historical data

2012 - 2015

Forecast period

2016 - 2022

Market representation

Revenue in USD Million & CAGR from 2015 to 2022

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, UK, Germany, France, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research, Inc. has segmented the hemostasis and tissue sealing agents market report on the basis of product type and region:

  • Type Outlook (Revenue, USD Million, 2012 - 2022)

    • Topical hemostat

    • Adhesive & tissue sealant

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,250
Multi User (2-5) - $5,250
Enterprise Access - $7,250

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified